Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool

Journal of Clinical Microbiology

Volumn 50, Issue 6, 2012, Pages 1936-1942

  Woods, Conan K ^a   Brumme, Chanson J ^a   Liu, Tommy F ^b   Chui, Celia K S ^a   Chu, Anna L ^a   Wynhoven, Brian ^a   Hall, Tom A ^c   Trevino, Christina ^b   Shafer, Robert W ^b   Harrigan, P Richard ^a,d  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Ibis Biosciences Inc   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ATAZANAVIR; DARUNAVIR; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ETRAVIRINE; FOSAMPRENAVIR; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; SAQUINAVIR; STAVUDINE; TENOFOVIR; TIPRANAVIR; ZIDOVUDINE;

ACCURACY; ALGORITHM; ANTIVIRAL RESISTANCE; ARTICLE; AUTOMATION; COMPUTER PROGRAM; DATA PROCESSING; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; LABORATORY PERSONNEL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCORING SYSTEM; SEQUENCE ANALYSIS; STANDARDIZATION; VALIDATION PROCESS; WORKFLOW;

ANTI-HIV AGENTS; AUTOMATION; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; SEQUENCE ANALYSIS; TIME FACTORS; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84862098342     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06689-11     Document Type: Article

References (20)

1. Anonymous. 2011. Ground-truth data cannot do it alone. Nat. Methods 8:885.
2. Baxter JD, et al. 2000. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. AIDS 14:F83-F93. (Pubitemid 30420686)
3. Brooks JI, et al. 2009. Evaluation of an automated sequence analysis tool to standardize HIV genotyping results, abstr O061. 18th Annu. Can. Conf. HIV/AIDS Res., Vancouver, Canada.
4. Cockerill FR, 3rd. 1999. Genetic methods for assessing antimicrobial resistance. Antimicrob. Agents Chemother. 43:199-212.
5. Cunningham S, et al. 2001. Performance of the Applied Biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samples. J. Clin. Microbiol. 39:1254-1257. (Pubitemid 32275416)
6. DeGruttola V, et al. 2000. The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir. Ther. 5:41-48. (Pubitemid 30261205)
7. Ewing B, Green P. 1998. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 8:186-194. (Pubitemid 28177230)
8. Ewing B, Hillier L, Wendl MC, Green P. 1998. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res. 8:175-185. (Pubitemid 28177229)
9. Galli RA, Sattha B, Wynhoven B, O'Shaughnessy MV, Harrigan PR. 2003. Sources and magnitude of intralaboratory variability in a sequencebased genotypic assay for human immunodeficiency virus type 1 drug resistance. J. Clin. Microbiol. 41:2900-2907. (Pubitemid 36842277)
10. Grant RM, et al. 2003. Accuracy of the TRUGENE HIV-1 genotyping kit. J. Clin. Microbiol. 41:1586-1593. (Pubitemid 36428108)
11. Huang DD, Eshleman SH, Brambilla DJ, Palumbo PE, Bremer JW. 2003. Evaluation of the editing process in human immunodeficiency virus type 1 genotyping. J. Clin. Microbiol. 41:3265-3272. (Pubitemid 36842332)
12. Johnson VA, et al. 2010. Update of the drug resistance mutations in HIV-1: December 2010. Top. HIV Med. 18:156-163.
13. Kuritzkes DR, et al. 2003. Performance characteristics of the TRUGENE HIV-1 genotyping kit and the Opengene DNA sequencing system. J. Clin. Microbiol. 41:1594-1599. (Pubitemid 36428109)
14. Liu TF, Shafer RW. 2006. Web resources for HIV type 1 genotypicresistance test interpretation. Clin. Infect. Dis. 42:1608-1618.
15. McGovern RA, et al. 2010. Population-based sequencing of the V3-loop is comparable to the enhanced sensitivity Trofile assay (ESTA) in predicting virologic response to maraviroc (MVC) of treatment-naïve patients in the MERIT Trial, abstr 92. 17th Conf. Retrovir. Opportun. Infect., San Francisco, CA.
16. McGovern RA, et al. 2010. Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies. AIDS 24:2517-2525.
17. Shafer RW, et al. 2001. High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients. J. Clin. Microbiol. 39:1522-1529. (Pubitemid 32275460)
18. Smith TF, Waterman MS. 1981. Identification of common molecular subsequences. J. Mol. Biol. 147:195-197.
19. Tilston P, et al. 2011. Evaluation of RECall automated basecalling software in HIV drug resistance testing, abstr P4. Eur. Soc. Clin. Virol. Winter Meet., London, United Kingdom.
20. Weinstein MC, et al. 2001. Use of genotypic resistance testing to guide HIV therapy: clinical impact and cost-effectiveness. Ann. Intern. Med. 134:440-450. (Pubitemid 32225945)